Although the agency did not recommend an extension of Opdualag’s indications, it did say new data could be added to its product information.
Medscape News Europe
Source link : https://www.medscape.com/viewarticle/ema-says-no-drug-pd-l1-high-melanoma-2026a1000d4z?src=rss
Author :
Publish date : 2026-04-24 15:54:00
Copyright for syndicated content belongs to the linked Source.
